Completed EUCTR 2009-018161-12
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Belgium Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance.
Countries United Kingdom, Belgium, Germany, ...
Sponsor Shire Development Inc
Condition ADHD Completed EUCTR 2010-020014-28
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Netherlands Why is this study shown? This study is directly about ADHD.
ADHD Drug
Countries Netherlands
Sponsor Centre for Human Drug Research
Condition ADHD Completed NCT00421603
This study is completed in the United States. It is testing mixed Amphetamine Salts and Topiramate for ADHD.
In New York Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 60 Years
Countries United States
Sponsor New York State Psychiatric Institute
Condition ADHD Completed NCT02250339
This summary needs review. Please check the official study record and contact the research team for details.
In Helsinki Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 5 Years to 12 Years
Countries Finland
Sponsor Social Insurance Institution, Finland
Condition ADHD Unknown NCT06479850
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 14 Years to 26 Years
Countries
Sponsor Kessler Foundation
Condition ADHD Completed NCT00236444
This study is completed. It is testing risperidone for ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 5 Years to 17 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition ADHD Completed NCT00250354
This study is completed. It is testing risperidone for ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 5 Years to 12 Years
Countries
Sponsor Janssen Pharmaceutica N.V., Belgium
Condition ADHD Completed NCT00266552
This study is completed. It is testing risperidone for ADHD.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug From 5 Years to 12 Years
Countries
Sponsor Janssen Pharmaceutica N.V., Belgium
Condition ADHD Completed NCT01199315
This study is completed in Japan. It focuses on ADHD.
In Fukuoka Why is this study shown? This study is directly about ADHD.
ADHD Drug From 20 Years to 80 Years
Countries Japan
Sponsor AstraZeneca
Condition ADHD Completed NCT02144415
This study is completed in the United States. It is testing Abuse Potential of EB-1020 Immediate-Release for ADHD.
In Overland Park Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition ADHD Completed NCT06966973
This summary needs review. Please check the official study record and contact the research team for details.
In Garches Why is this study shown? This study is directly about ADHD.
ADHD Observational i A study where researchers collect information without assigning a treatment. From 2 Years to 17 Years
Countries France
Sponsor UPNOS
Condition ADHD Completed NCT00486551
This summary needs review. Please check the official study record and contact the research team for details.
In New Haven Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 11 Years to 16 Years
Countries United States
Sponsor Yale University
Condition ADHD 
